在含水介质中钯高效催化咪唑并[1,2-a]吡啶类化合物与芳基氯代物的碳氢芳基化反应(英文)
详细信息    查看全文 | 推荐本文 |
  • 英文篇名:Efficient Pd-Catalyzed Direct C—H Bond Arylation of Imidazo-[1,2-a]pyridines with Aryl Chlorides in Aqueous Medium
  • 作者:穆兵 ; 李敬亚 ; 邹大鹏 ; 吴豫生 ; 常俊标 ; 吴养洁
  • 英文作者:Mu,Bing;Li,Jingya;Zou,Dapeng;Wu,Yusheng;Chang,Junbiao;Wu,Yangjie;School of Pharmaceutical Sciences,Zhengzhou University;College of Chemistry and Chemical Engineering,Zhengzhou Normal University;Tetranov Biopharm,LLC;College of Chemistry and Molecular Engineering,Zhengzhou University;
  • 关键词:碳氢芳基化 ; 咪唑并[1 ; 2-a]吡啶 ; 3-芳基咪唑并[1 ; 2-a]吡啶 ; 芳基/杂芳基氯代物 ; 含水介质
  • 英文关键词:C—H bond arylation;;imidazo[1,2-a]pyridines;;3-arylimidazo[1,2-a]pyridines;;aryl/heteroaryl chlorides;;aqueous medium
  • 中文刊名:YJHU
  • 英文刊名:Chinese Journal of Organic Chemistry
  • 机构:郑州大学药学院;郑州师范学院化学化工学院;郑州泰基鸿诺医药股份有限公司;郑州大学化学与分子工程学院;
  • 出版日期:2017-11-28 14:39
  • 出版单位:有机化学
  • 年:2018
  • 期:v.38;No.350
  • 基金:supported by the National Natural Science Foundation of China(No.21702191);; the Scientific and Technological Project of Henan Province(No.172102210555);; the Postdoctoral Science Foundation of Henan Province(No.2014003)~~
  • 语种:英文;
  • 页:YJHU201801010
  • 页数:8
  • CN:01
  • ISSN:31-1321/O6
  • 分类号:113-120
摘要
3-芳基咪唑并[1,2-a]吡啶骨架广泛存在于药物结构中,在药物学方面具有重要的地位及在材料化学、有机化学等方面也具有潜在的应用价值.在含水介质中,利用醋酸钯催化咪唑并[1,2-a]吡啶及其衍生物与芳基/杂芳基氯代物的碳氢芳基化反应,简便、高效地合成系列3-芳基咪唑并[1,2-a]吡啶类化合物,并以较好至优秀的收率获得芳基化产品.该方法采用廉价易得的芳基/杂芳基氯代物和咪唑并[1,2-a]吡啶类化合物为偶联反应的底物,且底物的范围能够拓展至缺电子、富电子的芳基氯代物和杂芳基氯代物及多种基团取代的咪唑并[1,2-a]吡啶类化合物.
        An efficient and practical protocol for palladium-catalyzed direct C—H bond arylation of imidazo[1,2-a]pyridines with cheap aryl/heteroaryl chlorides has been developed. Various imidazo[1,2-a]pyridines with electron-neutral, electron-poor, electron-rich, even sterically hindered aryl chlorides and heteroaryl chlorides were successfully applied to the reaction in aqueous medium to achieve the 3-arylimidazo[1,2-a]pyridines in mostly good to excellent yields, thus representing a significant advancement in the implementation of the direct C—H bond arylation of imidazo[1,2-a]pyridines with aryl chlorides.
引文
[1]Bagdi,A.K.;Santra,S.;Monir,K.;Hajra,A.Chem.Commun.2015,51,1555.
    [2]Moraski,G.C.;Markley,L.D.;Hipskind,P.A.;Boshoff,H.;Cho,S.;Franzblau,S.G.;Miller,M.J.ACS Med.Chem.Lett.2011,2,466.
    [3]Egner,U.;Gerbling,K.P.;Hoyer,G.A.;Krüger,G.;Wegner,P.Pestic.Sci.1996,47,145.
    [4]Bae,J.S.;Lee,D.W.;Lee,D.H.;Jeong,D.S.WO 2007011163,2007[Chem.Abstr.2007,146,193485].
    [5]El-Sayed,W.M.;Hussin,W.A.;Al-Faiyz,Y.S.;Ismail,M.A.Eur.J.Pharmacol.2013,715,212.
    [6]Lacerda,R.B.;de Lima,C.K.F.;da Silva,L.L.;Romeiro,N.C.;Miranda,A.L.P.;Barreiro,E.J.;Fraga,C.A.M.Bioorg.Med.Chem.2009,17,74.
    [7]Shukla,N.M.;Salunke,D.B.;Yoo,E.;Mutz,C.A.;Balakrishna,R.;David,S.A.Bioorg.Med.Chem.2012,20,5850.
    [8]Ismail,M.A.;Arafa,R.K.;Wenzler,T.;Brun,R.;Tanious,F.A.;Wilson,W.D.;Boykin,D.W.Bioorg.Med.Chem.2008,16,683.
    [9]Véron,J.B.;Allouchi,H.;Enguehard-Gueiffier,C.;Snoeck,R.;Andrei,G.;De Clercq,E.;Gueiffier,A.Bioorg.Med.Chem.2008,16,9536.
    [10]Kaminski,J.J.;Doweyko,A.M.J.Med.Chem.1997,40,427.
    [11]Rival,Y.;Grassy,G.;Taudon,A.;Ecalle,R.Eur.J.Med.Chem.1991,26,13.
    [12]Enguehard-Gueiffier,C.;Musiu,S.;Henry,N.;Véron,J.B.;Mavel,S.;Neyts,J.;Leyssen,P.;Paeshuyse,J.;Gueiffier,A.Eur.J.Med.Chem.2013,64,448.
    [13]Patel,H.S.;Linn,J.A.;Drewry,D.H.;Hillesheim,D.A.;Zuercher,W.J.;Hoekstra,W.J.Tetrahedron Lett.2003,44,4077.
    [14]Liu,G.P.;Cong,X.F.;He,J.H.;Luo,S.Z.;Wu,D.;Lan,J.B.J.Chem.Res.2012,36,687.
    [15]Wu,Z.Q.;Pan,Y.Y.;Zhou,X.G.Synthesis 2011,2255.
    [16]Dixon,L.I.;Carroll,M.A.;Gregson,T.J.;Ellames,G.J.;Harrington,R.W.;Clegg,W.Org.Biomol.Chem.2013,11,5877.
    [17]Collins,M.R.;Huang,Q.;Ornelas,M.A.;Scales,S.A.Tetrahedron Lett.2010,51,3528.
    [18]Monir,K.;Bagdi,A.K.;Ghosh,M.;Hajra,A.Org.Lett.2014,16,4630.
    [19]Enguehard,C.;Renou,J.L.;Collot,V.;Hervet,M.;Rault,S.;Gueiffier,A.J.Org.Chem.2000,65,6572.
    [20]Marhadour,S.;Bazin,M.A.;Marchand,P.Tetrahedron Lett.2012,53,297.
    [21]Nandi,D.;Jhou,Y.M.;Lee,J.Y.;Kuo,B.C.;Liu,C.Y.;Huang,P.W.;Lee,H.M.J.Org.Chem.2012,77,9384.
    [22]Karale,U.B.;Kalari,S.;Shivakumar,J.;Makane,V.B.;Babar,D.A.;Thakare,R.P.;Nagendra Babu,B.;Chopra,S.;Rode,H.B.RSC Adv.2016,6,65095.
    [23]Mu,B.;Wu,Y.S.;Li,J.Y.;Zou,D.P.;Chang,J.B.;Wu,Y.J.Org.Biomol.Chem.2016,14,246.
    [24]Lee,J.;Chung,J.;Byun,S.M.;Kim,B.M.;Lee,C.Tetrahedron2013,69,5660.
    [25]Fu,H.Y.;Chen,L.;Doucet,H.J.Org.Chem.2012,77,4473.
    [26]Nandi,D.;Siwal,S.S.;Mallick,K.Chemistry Select 2017,2,1747.
    [27]Cao,H.;Zhan,H.Y.;Lin,Y.G.;Lin,X.L.;Du,Z.D.;Jiang,H.F.Org.Lett.2012,14,1688.
    [28]Kalari,S.;Babar,D.A.;Karale,U.B.;Makane,V.B.;Rode,H.B.Tetrahedron Lett.2017,58,2818.
    [29]Choy,P.Y.;Luk,K.C.;Wu,Y.N.;So,C.M.;Wang,L.L.;Kwong,F.Y.J.Org.Chem.2015,80,1457.
    [30]Cao,H.;Lin,Y.G.;Zhan,H.Y.;Du,Z.D.;Lin,X.L.;Liang,Q.M.;Zhang,H.RSC Adv.2012,2,5972.
    [31]Liu,Q.X.;He,B.Y.;Qian,P.C.;Shao,L.X.Org.Biomol.Chem.2017,15,1151.
    [32]Zhao,G.K.;Zhang,K.N.;Wang,L.;Li,J.Y.;Zou,D.P.;Wu,Y.J.;Wu,Y.S.Tetrahedron Lett.2015,56,6700.
    [33]Ke,C.H.;Kuo,B.C.;Nandi,D.;Lee,H.M.Organometallics2013,32,4775.
    [34]Frett,B.;Mc Connell,N.;Smith,C.C.;Wang,Y.X.;Shah,N.P.;Li,H.Y.Eur.J.Med.Chem.2015,94,123.
    [35]Hiebel,M.A.;Fall,Y.;Scherrmann,M.C.;Berteina-Raboin,S.Eur.J.Org.Chem.2014,2014,4643.
    [36]Cooper,K.;Fray,M.J.;Parry,M.J.;Richardson,K.;Steele,J.J.Med.Chem.1992,35,3115.